660
Views
12
CrossRef citations to date
0
Altmetric
Review

Home oxygen therapy: re-thinking the role of devices

, &
Pages 279-289 | Received 09 Jan 2017, Accepted 21 Dec 2017, Published online: 04 Jan 2018

References

  • Hardinge M, Annandale J, Bourne S, et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax. 2015;70(Suppl 1):i1–i43.
  • McDonald CF, Whyte K, Jenkins S, et al. Clinical practice guideline on adult domiciliary oxygen therapy: executive summary from the Thoracic Society of Australia and New Zealand. Respirology. 2016;21(1):76–78.
  • Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD). 2017 [cited 2017 Jun 27]. Available from: http://goldcopd.org.
  • O’Driscoll BR, Howard LS, Davison AG, et al. BTS guideline for emergency oxygen use in adult patients. Thorax. 2008;63(Suppl 6):vi1–68.
  • Beasley R, Chien J, Douglas J, et al. Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: ‘swimming between the flags’. Respirology. 2015;20(8):1182–1191.
  • Cousins JL, Wark PA, McDonald VM. Acute oxygen therapy: a review of prescribing and delivery practices. Int J Chron Obstruct Pulmon Dis. 2016;11:1067–1075.
  • McCoy RW. Options for home oxygen therapy equipment: storage and metering of oxygen in the home. Respir Care. 2013;58(1):65–85.
  • Palwai A, Skowronski M, Coreno A, et al. Critical comparisons of the clinical performance of oxygen conserving devices. Am J Respir Crit Care Med. 2010;181(10):1061–1071.
  • Martí S, Pajares V, Morante F, et al. Are oxygen-conserving devices effective for correcting exercise hypoxemia? Respir Care. 2013;58(10):1606–1613.
  • Diaz Lobato S, Garcia Gonzalez JL, Alises SM. The debate on continuous home oxygen therapy. Arch Bronconeumol. 2015;51(1):31–37.
  • Turnbull H, Conroy A, Opoka RO, et al. Solar-powered oxygen delivery: proof of concept. Int J Tuberc Lung Dis. 2016;20(5):696–703.
  • Diego Gonzalez EG, Mendez Lanza A, Mosquera Pestana JA. Noise and machine failures: determining factors in the acceptance and behavior of O2 concentrator. The Asturias project. An Med Interna. 1996;13(9):430–433.
  • Chatburn RL, Williams TJ. Performance comparison of 4 portable oxygen concentrators. Respir Care. 2010;55(4):433–442.
  • LeBlanc CJ, Lavallée LG, King JA, et al. A comparative study of 3 portable oxygen concentrators during a 6-minute walk test in patients with chronic lung disease. Respir Care. 2013;58(10):1598–1605.
  • Katz I, Pichelin M, Montesantos S, et al. An in silico analysis of oxygen uptake of a mild COPD patient during rest and exercise using a portable oxygen concentrator. Int J Chron Obstruct Pulmon Dis. 2016;11:2427–2434.
  • Nasilowski J, Przybylowski T, Zielinski J, et al. Comparing supplementary oxygen benefits from a portable oxygen concentrator and a liquid oxygen portable device during a walk test in COPD patients on long-term oxygen therapy. Respir Med. 2008;102(7):1021–1025.
  • Lewarski J, Mikus G, Andrews G, et al. A clinical comparison of portable oxygen systems: continuous flow compressed gas vs. oxygen concentrator gas delivered with an oxygen conserving device. Respir Care. 2003;48(11):1115.
  • Zhou S, Chatburn RL. Effect of the anatomic reservoir on low-flow oxygen delivery via nasal cannula: constant flow versus pulse flow with portable oxygen concentrator. Respir Care. 2014;59(8):1199–1209.
  • Yáñez AM, Prat JP, Álvarez-Sala JL, et al. Oxygenation with a single portable pulse-dose oxygen-conserving device and combined stationary and portable oxygen delivery devices in subjects with COPD. Respir Care. 2015;60(3):382–387.
  • Cuvelier A, Chakroun N, Onea G, et al. Refillable oxygen cylinders may be an alternative for ambulatory oxygen therapy in COPD. Chest. 2002;122:451–456.
  • Murphie P, Hex N, Setters J, et al. Self-fill oxygen technology: benefits for patients, healthcare providers and the environment. Breathe (Sheff). 2016;12(2):113–119.
  • Godoy I, Tanni SE, Hernández C, et al. The importance of knowing the home conditions of patients receiving long-term oxygen therapy. Int J Chron Obstruct Pulmon Dis. 2012;7:421–425.
  • Aguiar C, Davidson J, Carvalho AK, et al. Tubing length for long-term oxygen therapy. Respir Care. 2015;60(2):179–182.
  • Neri M, Melani AS, Miorelli AM, et al.; on behalf of the Educational Study Group of the Italian Association of Hospital Pulmonologists (AIPO). Long-term oxygen therapy in chronic respiratory failure: a Multicenter Italian Study on Oxygen Therapy Adherence (MISOTA). Respir Med. 2006;100:795–806.
  • Ward JJ. High-flow oxygen administration by nasal cannula for adult and perinatal patients. Respir Care. 2013;58(1):98–120.
  • Roca O, Hernández G, Díaz-Lobato S, et al.; on behalf of the Spanish Multidisciplinary Group of High Flow Supportive Therapy in Adults (HiSpaFlow). Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure. Crit Care. 2016;20(1):109.
  • Pretto JJ, Roebuck T, Beckert L, et al. Clinical use of pulse oximetry: official guidelines from the Thoracic Society of Australia and New Zealand. Respirology. 2014;19(1):38–46.
  • Jubran A. Pulse oximetry. Critical Care. 2015;19:272.
  • Gregersen TL, Green A, Frausing E, et al. Do telemedical interventions improve quality of life in patients with COPD? A systematic review. Int J Chron Obstruct Pulmon Dis. 2016;11:809–822.
  • Ambrosino N, Vitacca M, Dreher M, et al.; on beahlf of the ERS Tele-Monitoring of Ventilator-Dependent Patients Task Force. Tele-monitoring of ventilator-dependent patients: a European Respiratory Society statement. Eur Respir J. 2016;48(3):648–663.
  • Cirio S, Nava S. Pilot study of a new device to titrate oxygen flow in hypoxic patients on long-term oxygen therapy. Respir Care. 2011;56(4):429–434.
  • Rice KL, Schmidt MF, Buan JS, et al. AccuO2 oximetry-driven oxygen-conserving device versus fixed-dose oxygen devices in stable COPD patients. Respir Care. 2011;56(12):1901–1905.
  • Lellouche F, L’Her E. Automated oxygen flow titration to maintain constant oxygenation. Respire Care. 2012;57(8):1254–1262.
  • Lellouche F, Bouchard P-A, Roberge M, et al. Automated oxygen titration and weaning with FreeO2 in patients with acute exacerbation of COPD: a pilot randomized trial. Int J Chron Obstruct Pulmon Dis. 2016;11:1983–1990.
  • Lellouche F, L’Her E, Bouchard P-A, et al. Automatic oxygen titration during walking in subjects with COPD: a randomized crossover controlled study. Respir Care. 2016;61(11):1456–1464.
  • Gangidine MM, Blakeman TC, Branson RD, et al. System design verification for closed loop control of oxygenation with concentrator integration. Mil Med. 2016;181(5 Suppl):177–183.
  • Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet. 1981;1:681–686.
  • NOTT. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980;93:391–398.
  • Long-Term Oxygen Treatment Trial Research Group. The randomized trial of Long-Term Oxygen for COPD with moderate desaturation. N Engl J Med. 2016;375(17):1617–1627.
  • Eaton T, Lewis C, Young P, et al. Long-term oxygen therapy improves health-related quality of life. Respir Med. 2004;98:285–293.
  • Raghu G, Rochwerg B, Zhang Y, et al.; on behalf of the American Thoracic Society, European Respiratory society, Japanese Respiratory Society, Latin American Thoracic Association. An official ATS/ERS/JRS/ALAT Clinical Practice Guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med. 2015; 192(2):e3–19.
  • Visca D, Tsipouri V, Mori L, et al. AMBOX: a randomized controlled cross-over trial evaluating the effects of ambulatory oxygen on health status in patients with fibrotic. Interstial lung disease. Am J Respir Crit Care Med. 2017;195:A7603.
  • Clark AL, Johnson M, Fairhurst C, et al. Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure. Health Technol Assess. 2015;19(75):1–120.
  • Katsenos S, Constantopoulos SH. Long-Term Oxygen Therapy in COPD: factors affecting and ways of improving patient compliance. Pulm Med. 2011;2011:325362.
  • Casaburi R, Porszasz J, Hecht A, et al.; On behalf of the COPD Clinical Research Network. Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. COPD. 2012;9(1):3–11.
  • Lin SK, Bogen DK, Kuna ST. Validation of a novel device to objectively measure adherence to long-term oxygen therapy. Int J Chron Obstruct Pulmon Dis. 2008;3(3):435–442.
  • Holden E, Jackson M. A pilot trial in healthy volunteers to determine the reliability and accuracy of the oxygen compliance monitor, oxymon. J Med Eng Technol. 2009;33(8):604–609.
  • Vergeret J, Brambilla C, Mounier L. Portable oxygen therapy: use and benefit in hypoxaemic COPD patients on long-term oxygen therapy. Eur Respir J. 1989;2:20–25.
  • Kampelmacher MJ, Van Kestern RG, Alsbach GP, et al. Characteristics and complaints of patients prescribed long-term oxygen therapy in The Netherlands. Respir Med. 1998;92(1):70–75.
  • Su C-L, Lee C-N, Chen H-C, et al. Comparison of domiciliary oxygen using liquid oxygen and concentrator in northern Taiwan. J Formos Med Assoc. 2014;113(1):23–32.
  • Lacasse Y, Lecours R, Pelletier C, et al. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J. 2005;25:1032–1038.
  • Arnold E, Bruton A, Donovan-Hall M, et al. Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study. BMC Pulm Med. 2011;6:11.
  • Plywaczewski R, Sliwinski P, Nowinski A, et al. Incidence of nocturnal desaturation while breathing oxygen in COPD patients undergoing long-term oxygen therapy. Chest. 2000;117(3):679–683.
  • Wijkstra PJ, Guyatt GH, Ambrosino N, et al. International approaches to the prescription of long-term oxygen therapy. Eur Respir J. 2001;18(6):909–913.
  • Lewis CA, Fergusson W, Eaton T, et al. Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax. 2009;64:133–138.
  • Lacasse Y, Sériès F, Vujovic-Zotovic N, et al. Evaluating nocturnal oxygen desaturation in COPD-revised. Respir Med. 2011;105(9):1331–1337.
  • Mehta V, Vasu TS, Phillips B, et al. Obstructive sleep apnea and oxygen therapy: a systematic review of the literature and meta-analysis. J Clin Sleep Med. 2013;9(3):271–279.
  • Masa JF, Corral J, Romero A, et al.; on behalf of the Spanish Sleep Network. The effect of supplemental oxygen in Obesity Hypoventilation Syndrome. J Clin Sleep Med. 2016;12(10):1379–1388.
  • Bordier P, Lataste A, Hofmann P, et al. Nocturnal oxygen therapy in patients with chronic heart failure and sleep apnea: a systematic review. Sleep Med. 2016;17:149–157.
  • Fletcher EC, Luckett RA, Goodnight-White S, et al. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis. 1992;145(5):1070–1076.
  • Chaouat A, Weitzenblum E, Kessler R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J. 1999;14(5):1002–1008.
  • Lacasse Y, Series F, Martin S, et al. Nocturnal oxygen therapy in patients with chrocni obstructive pulmonary disease: a survey of Canadian pulmonologists. Can Respir J. 2007;14(6):343–348.
  • Lacasse Y, Bernard S, Sériès F, et al.; for the International Nocturnal Oxygen (INOX) Research Group. Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial. BMC Pulm Med. 2017;17(1):8.
  • Ekström M, Ahmadi Z, Bornefalk-Hermansson A, et al. Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy. Cochrane Database Syst Rev. 2016;11:CD006429.
  • Moore RP, Berlowitz DJ, Denehy L, et al. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax. 2011;66:32–37.
  • Eaton T, Garrett JE, Young P, et al. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J. 2002;20:306–312.
  • McDonald CF, Blyth CM, Lazarus MD, et al. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med. 1995;152(5 Pt 1):1616–1619.
  • Alison JA, McKeough ZJ, Jenkins SC, et al. A randomised controlled trial of supplemental oxygen versus medical air during exercise training in people with chronic obstructive pulmonary disease: supplemental oxygen in pulmonary rehabilitation trial (SuppORT) (Protocol). BMC Pulm Med. 2016;16:25.
  • O’Donnell DE, Neder JA, Harle I, et al. Chronic breathlessness in patients with idiopathic pulmonary fibrosis: a major challenge for caregivers. Expert Rev Respir Med. 2016;10(12):1295–1303.
  • Sharp C, Adamali H, Millar AB. Ambulatory and short burst oxygen for interstitial lung disease. Cochrane Database Syst Rev. 2016;7:CD011716.
  • Bell EC, Cox NS, Goh N, et al. Oxygen therapy for interstitial lung disease: a systematic review. Eur Respir Rev. 2017;26:1–7.
  • Nishiyama O, Miyajima H, Fukai Y, et al. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia. Respir Med. 2013;107(8):1241–1246.
  • Belkin A, Fier K, Albright K, et al. Protocol for a mixed-methods study of supplemental oxygen in pulmonary fibrosis. BMC Pulm Med. 2014;14:169.
  • Ryerson CJ, Camp PG, Eves ND, et al. High oxygen delivery to preserve exercise capacity in patients with idiopathic pulmonary fibrosis treated with nintedanib. Methodology of the HOPE-IPF study. Ann Am Thorac Soc. 2016;13(9):1640–1647.
  • Harris-Eze AO, Sridhar G, Clemens RE, et al. Oxygen improves maximal exercise performance in interstitial lung disease. Am J Respir Crit Care Med. 1994;150(6 part 1):1616–1622.
  • Snider G. Enhancement of exercise performance in COPD by hyperoxia. Chest. 2002;122:1830–1836.
  • Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet. 2010;376:784–793.
  • Ekstrom MP, Bornefalk Hermansson A, Strom KE. Effects of cardiovascular drugs on mortality in severe COPD: a time-dependent analysis. Am J Respir Crit Care Med. 2013;187(7):715–720.
  • Ringbaek TJ, Lange P. Trends in long-term oxygen therapy for COPD in Denmark from 2001 to 2010. Respir Med. 2014;108:511–516.
  • Nishi SP, Zhang W, Kuo YF, et al. Oxygen therapy use in older adults with chronic obstructive pulmonary disease. PLoS One. 2015;10(3):e0120684.
  • Corrado A, Rebda T, Bertini S. Long-term oxygen therapy in COPD: evidences and open questions of current indications. Monaldi Arch Chest Dis. 2010 Mar;73(1):34–43.
  • Magnet FS, Schwarz SB, Callegari J, et al. Long-term oxygen therapy: comparison of the German and British guidelines. Respiration. 2017;93(4):253–263.
  • Furlanetto KC, Pitta F. Oxygen therapy devices and portable ventilators for improved physical activity in daily life in patients with chronic respiratory disease. Expert Rev Med Devices. 2017;14(2):103–115.
  • Schaanning J, Strom K, Boe J. Do patients using long-term liquid oxygen differ from those on traditional treatment with oxygen concentrators and/or compressed gas cylinders? A comparison of two national registers. Respir Med. 1998;92:84–87.
  • Andersson A, Strom K, Brodin H, et al. Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis. Eur Respir J. 1998;12:1284–1289.
  • Khor YH, McDonald CF, Hazard A, et al. Portable oxygen concentrators versus oxygen cylinder during walking in interstitial lung disease: a randomized crossover trial. Respirology. 2017 Nov;22(8):1598–1603.
  • Kelly CA, O’Brien MR. Difficult decisions: an interpretative phenomenological analysis study of healthcare professionals’ perceptions of oxygen therapy in palliative care. Palliat Med. 2015;29(10):950–958.
  • Collier A, Breaden K, Phillips JL, et al. Caregivers’ perspectives on the use of Long-Term Oxygen Therapy for the treatment of refractory breathlessness: a qualitative study. J Pain Symptom Manage. 2017;53:33–39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.